Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Erika J. Sims
Add-On Therapy With Montelukast or Formoterol in Patients With the Glycine-16 Β2-Receptor Genotype
British Journal of Clinical Pharmacology
Pharmacology
Related publications
The Arginine-16 Β2-Adrenoceptor Polymorphism Predisposes to Bronchoprotective Subsensitivity in Patients Treated With Formoterol and Salmeterol
British Journal of Clinical Pharmacology
Pharmacology
Topiramate Add-On Therapy for Adult Patients With Refractory Epilepsy in Japan
Epilepsy and Seizure
Neurology
Magnitude of a Conformational Change in the Glycine Receptor Β1-Β2 Loop Is Correlated With Agonist Efficacy
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Fludarabine Add-On Therapy in Interferon-Beta-Treated Patients With Multiple Sclerosis Experiencing Breakthrough Disease
Therapeutic Advances in Neurological Disorders
Neurology
Pharmacology
Autoantibodies Activating the Β2-Adrenergic Receptor Characterize Patients With Primary and Secondary Glaucoma
Frontiers in Immunology
Allergy
Immunology
The Effect of Denervation and Treatment With the Β2-Agonist, Formoterol, on the Masseter Muscles of Growing Sprague Dawley Rats
International Journal of Dentistry and Oral Health
Erratum To: Evaluation of Add-On Therapy of Sitagliptin in Japanese Patients With Type 2 Diabetes Under Insulin Therapy
Diabetology International
Internal Medicine
Endocrinology
Metabolism
Diabetes
Economic Impact of Asthma Therapy With Fluticasone Propionate, Montelukast, or Zafirlukast in a Managed Care Population
Pharmacotherapy
Pharmacology
Β2-Adrenergic Receptor-Mediated Histamine H1 Receptor Down-Regulation: Another Possible Advantage of Β2 Agonists in Asthmatic Therapy
Journal of Pharmacological Sciences
Molecular Medicine
Pharmacology